健康英语新闻:Chinese scientists make breakthrough in leprosy treatment
JINAN, Oct. 24 (Xinhua) -- Chinese scientists have made a breakthrough that could lead to more effective treatments for leprosy.
A team from Shandong Provincial Institute of Dermatology and Venereology in east China has identified two new risk variants near IL23R and RAB 32 genes that are responsible for the disease, according to a report published online Monday in the scientific journal Nature Genetics.
Knowing that the two gene variants influence susceptibility to leprosy could allow doctors to diagnose the disease in sufferers earlier in its outset, as well as to develop new treatments. A genetic database could now be built up to predict those people particularly susceptible to leprosy, said Zhang Furen, the leader of the research team.
The study involved more than 10,000 samples being taken from leprosy sufferers and healthy test subjects and analysed.
Leprosy is a chronic nerve-killing disease that leads to problems with patients' skin, feet, hands, legs and eyes. More than 200,000 newly-contracted leprosy cases are reported worldwide every year, and China has around one tenth of the world's sufferers.
相关文章
- 英语文摘:China urges G7 to cease interfering in its internal affairs
- 英语文摘:HKSAR gov't strongly refutes G7, EU statements on chief executive election
- 英语文摘:Xi's keynote speech at opening ceremony of Boao Forum for Asia Annual Conference 2022 publ
- 英语文摘:Xi attends ceremony marking centenary of Communist Youth League of China
- 英语文摘:Xi talks with Macron over phone
- 英语文摘:External interference in Hong Kong affairs doomed to be self-defeating: Commissioner's off
- 英语文摘:Chinese spokesperson slams Western countries smearing Hong Kong election
- 英语文摘:China calls for equal, balanced global development partnership
- 英语文摘:Xinhua Headlines: A look at younger generation on China's new journey
- 英语文摘:Chinese vice premier reiterates dynamic zero-COVID policy